Amagasaki-city, Japan Clinical Trials

A listing of Amagasaki-city, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 61 clinical trials
Post-marketing Surveillance of EVRENZO Tablets (Roxadustat) in Dialysis-dependent Patients With Renal Anemia

The purpose of this study is to assess the safety and efficacy, including the incidence of thromboembolism, in renal anemia patients on dialysis treated with roxadustat (EVRENZO Tablets) in actual clinical settings.

dialysis
Site JP00027
 (6.1 away) Contact site
  • 5 views
  • 24 Sep, 2021
  • +46 other locations
A Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

carfilzomib
dexamethasone
cancer
refractory multiple myeloma
line of therapy
Investigational Site Number 3920009
 (8.2 away) Contact site
  • 0 views
  • 27 Aug, 2021
  • +57 other locations
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy DR)

Diabetic retinopathy (DR) is a diabetes complication caused by damage to the small blood vessels inside the retina at the back of the eye. Diabetic retinopathy may cause mild vision problems or eventually blindness. Diabetes is a condition that makes your blood sugar levels higher than they should be. In …

background diabetic retinopathy
edema
proliferative diabetic retinopathy
blindness
diabetic retinopathy
Osaka General Medical Center
 (9.8 away) Contact site
  • 74 views
  • 12 Sep, 2021
  • +83 other locations
Computerized Registry of Patients With Venous Thromboembolism (RIETE)

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the …

deep vein thrombosis
thrombosis
pulmonary embolism
venous thromboembolism
anticoagulation therapy
Hyogo Prefectural Amagasaki General Medical Center
 (0.5 away) Contact site
  • 6 views
  • 16 May, 2021
  • +201 other locations
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-na ve Prostate Cancer in Japan

The purpose of this registry study is to longitudinally observe clinical outcomes and patient-reported outcomes (PRO) for participants with high-risk metastatic hormone-naive prostate cancer (mHNPC) in the real-world setting in Japan.

adenocarcinoma
docetaxel
metastatic prostate cancer
androgens
adenocarcinoma of prostate
Osaka International Cancer Institute
 (7.2 away) Contact site
  • 79 views
  • 25 Aug, 2021
  • +104 other locations
A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns Effect of the Treatment Patient Outcomes and Patient Quality of Life

DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine clinical care.

renal failure
nephropathy
dialysis
renal replacement therapy
Research Site
 (8.3 away) Contact site
  • 32 views
  • 21 Aug, 2021
  • +35 other locations
A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

The purpose of this non-interventional study is to identify participants with urothelial cancer (UC) and selected fibroblast growth factor receptor (FGFR) aberrations through molecular testing of their archival tumor tissue.

carcinoma
transitional cell carcinoma
growth factor
Otemae Hospital
 (7.2 away) Contact site
  • 111 views
  • 15 Sep, 2021
  • +265 other locations
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

The objective of this study is to investigate the safety and effectiveness in routine clinical practice and actual clinical setting for all patients with rheumatoid arthritis (RA) treated with peficitinib.

Site JP00027
 (6.1 away) Contact site
  • 2 views
  • 22 Sep, 2021
  • +46 other locations
A Study of Equfina on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)

The purpose of the study is to investigate the incidences of psychiatric symptoms (example, hallucinations), somnolence and sudden onset of sleep, dyskinesia, and retinal degeneration-related events during treatment with Equfina in participants with parkinson's disease (including participants with hepatic impairment).

Eisai Trial Site 2
 (6.1 away) Contact site
  • 0 views
  • 16 Apr, 2021
  • +1 other locations
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

This is a multi-center observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer(NSCLC) or extensive disease small cell lung cancer(ED-SCLC). 800 patients in NSCLC cohort and 400 patients in ED-SCLC cohort will be enrolled in this trial to assess the efficacy and …

lung carcinoma
recurrent non-small cell lung cancer
atezolizumab
Hyogo Prefectural Amagasaki General Medical Center
 (0.5 away) Contact site
  • 0 views
  • 02 Jul, 2021
  • +154 other locations